{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:07:41Z","timestamp":1791115661001,"version":"4.1.0"},"reference-count":56,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2014.00061","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T07:23:47Z","timestamp":1403249027000},"source":"Crossref","is-referenced-by-count":36,"title":["New Experimental Treatments for Core Social Domain in Autism Spectrum Disorders"],"prefix":"10.3389","volume":"2","author":[{"given":"Roberto","family":"Canitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2040-2392-4-12","article-title":"DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes","volume":"4","author":"Grzadzinski","year":"2013","journal-title":"Mol Autism"},{"issue":"3","key":"B2","first-page":"1","article-title":"Prevalence of autism spectrum disorders \u00e2\u20ac\u201c autism and developmental disabilities monitoring network, 14 sites, United States, 2008","volume":"61","year":"2012","journal-title":"MMWR Surveill Summ"},{"issue":"3","key":"B3","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1542\/peds.2011-1145","article-title":"Prevalence of autism spectrum disorders in Hispanic and non-Hispanic white children","volume":"129","author":"Pedersen","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"B4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00127-011-0350-3","article-title":"Prevalence of autism spectrum disorders and influence of country of measurement and ethnicity","volume":"47","author":"Zaroff","year":"2012","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Research units on pediatric psychopharmacology autism network (2002). Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1089\/cap.2005.15.869","article-title":"Acute and long-term safety and tolerability of risperidone in children with autism","volume":"15","author":"Aman","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"B7","doi-asserted-by":"publisher","first-page":"CD009043","DOI":"10.1002\/14651858.CD009043.pub2","article-title":"Aripiprazole for autism spectrum disorders (ASD)","volume":"16","author":"Ching","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"B8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1517\/14656566.2011.557661","article-title":"Aripiprazole for the treatment of irritability associated with autism","volume":"2011","author":"Farmer","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.gde.2013.02.003","article-title":"Recent developments in the genetics of autism spectrum disorders","volume":"23","author":"Murdoch","year":"2013","journal-title":"Curr Opin Genet Dev"},{"key":"B10","article-title":"The promising trajectory of autism therapeutics discovery","volume-title":"Drug Discov Today","author":"Silverman","year":"2013"},{"key":"B11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav"},{"issue":"7363","key":"B12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature10360","article-title":"Neocortical excitation\/inhibition balance in information processing and social dysfunction","volume":"477","author":"Yizhar","year":"2011","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnmol.2013.00019","article-title":"Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses","volume":"6","author":"Won","year":"2013","journal-title":"Front Mol Neurosci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e36981","DOI":"10.1371\/journal.pone.0036981","article-title":"The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and Fragile X syndrome","volume":"7","author":"Wei","year":"2012","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainresbull.2011.08.001","article-title":"Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: possible implications for the pharmacotherapy of autism spectrum disorders","volume":"86","author":"Burket","year":"2011","journal-title":"Brain Res Bull"},{"issue":"4","key":"B16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/npp.2009.201","article-title":"Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP","volume":"35","author":"Silverman","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"131","key":"B17","doi-asserted-by":"publisher","first-page":"131ra51","DOI":"10.1126\/scitranslmed.3003501","article-title":"Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism","volume":"4","author":"Silverman","year":"2012","journal-title":"Sci Transl Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neuropharm.2012.07.013","article-title":"AMPAKINE enhancement of social interaction in the BTBR mouse model of autism","volume":"64","author":"Silverman","year":"2013","journal-title":"Neuropharmacology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2011.12.040","article-title":"d-cycloserine improves sociability and spontaneous stereotypic behaviors in 4-week old mice","volume":"1439","author":"Deutsch","year":"2012","journal-title":"Brain Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2040-2392-1-15","article-title":"Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication","volume":"17","author":"Bozdagi","year":"2010","journal-title":"Mol Autism"},{"issue":"19","key":"B21","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.1523\/JNEUROSCI.6107-11.2012","article-title":"Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice","volume":"32","author":"Yang","year":"2012","journal-title":"J Neurosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.rasd.2013.12.009","article-title":"Glutamatergic agents in ASD: current trends","volume":"8","author":"Canitano","year":"2014","journal-title":"Res Autism Spectr Disord"},{"issue":"9","key":"B23","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.neubiorev.2012.07.005","article-title":"GABA system dysfunction in autism and related disorders: from synapse to symptoms","volume":"36","author":"Coghlan","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.expneurol.2013.01.021","article-title":"Loss of GABAergic neurons in the hippocampus and cerebral cortex of Engrailed-2 null mutant mice: implications for autism spectrum disorders","volume":"247","author":"Sgad\u00c3\u00b2","year":"2013","journal-title":"Exp Neurol"},{"issue":"1","key":"B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/2040-2392-4-51","article-title":"Transcriptome profiling in engrailed-2 mutant mice reveals common molecular pathways associated with autism spectrum disorders","volume":"4","author":"Sgad\u00c3\u00b2","year":"2013","journal-title":"Mol Autism"},{"issue":"7","key":"B26","doi-asserted-by":"publisher","first-page":"e40914","DOI":"10.1371\/journal.pone.0040914","article-title":"Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice","volume":"7","author":"Brielmaier","year":"2012","journal-title":"PLoS One"},{"issue":"7321","key":"B27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signaling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"issue":"152","key":"B28","doi-asserted-by":"publisher","first-page":"ra128","DOI":"10.1126\/scitranslmed.3004218","article-title":"Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen","volume":"4","author":"Henderson","year":"2012","journal-title":"Sci Transl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.gde.2012.02.002","article-title":"New perspectives on the biology of fragile X syndrome","volume":"22","author":"Wang","year":"2012","journal-title":"Curr Opin Genet Dev"},{"issue":"152","key":"B30","doi-asserted-by":"publisher","first-page":"ra127","DOI":"10.1126\/scitranslmed.3004214","article-title":"Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial","volume":"4","author":"Berry-Kravis","year":"2012","journal-title":"Sci Transl Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10803-013-1963-z","article-title":"STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study","volume":"44","author":"Erickson","year":"2013","journal-title":"J Autism Dev Disord"},{"key":"B32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fncel.2013.00028","article-title":"Reversing autism by targeting downstream mTOR signaling","volume":"7","author":"Wang","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"8862","DOI":"10.1523\/JNEUROSCI.1617-11.2011","article-title":"Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function","volume":"31","author":"Bateup","year":"2011","journal-title":"J Neurosci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1523\/JNEUROSCI.0061-11.2011","article-title":"PTEN knockdown in vivo increases excitatory drive onto dentate granule cells","volume":"31","author":"Luikart","year":"2011","journal-title":"J Neurosci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.conb.2012.04.008","article-title":"Targeted treatment trials for tuberous sclerosis and autism: no longer a dream","volume":"22","author":"Sahin","year":"2012","journal-title":"Curr Opin Neurobiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainresbull.2013.11.005","article-title":"Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)\/J mouse model of autism spectrum disorders","volume":"100","author":"Burket","year":"2014","journal-title":"Brain Res Bull"},{"key":"B37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature11628","article-title":"Autism-related deficits via dysregulated eIF4E-dependent translational control","volume":"493","author":"Gkogkas","year":"2013","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nature11782","article-title":"Exaggerated translation causes synaptic and behavioural aberrations associated with autism","volume":"493","author":"Santini","year":"2013","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ejhg.2012.175","article-title":"Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders","volume":"21","author":"Boccuto","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/dneu.20778","article-title":"Toward a comprehensive neurobiology of IGF-I","volume":"70","author":"Torres-Aleman","year":"2010","journal-title":"Dev Neurobiol"},{"issue":"4","key":"B41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2040-2392-4-9","article-title":"Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay","volume":"27","author":"Bozdagi","year":"2013","journal-title":"Mol Autism"},{"key":"B42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nature12618","article-title":"SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients","volume":"503","author":"Shcheglovitov","year":"2013","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fpsyt.2012.00034","article-title":"Rett syndrome: genes, synapses, circuits, and therapeutics","volume":"3","author":"Banerjee","year":"2012","journal-title":"Front Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0910249107","article-title":"Promoting social behavior with oxytocin in high-functioning autism spectrum disorders","volume":"107","author":"Andari","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0079-6123(08)00435-4","article-title":"Oxytocin and experimental therapeutics in autism spectrum disorders","volume":"170","author":"Bartz","year":"2008","journal-title":"Prog Brain Res"},{"key":"B47","first-page":"20","article-title":"Social communication is an emerging target for pharmacotherapy in autism spectrum disorder \u00e2\u20ac\u201c a review of the literature on potential agents","volume":"23","author":"Baribeau","year":"2014","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastalla","year":"2010","journal-title":"Biol Psychiatry"},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2014.01.049","article-title":"Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth","volume-title":"Brain Res","author":"Anagnostou","year":"2014"},{"key":"B50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/cap.2012.0048","article-title":"Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders","volume":"23","author":"Tachibana","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10803-013-1899-3","article-title":"Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial","volume":"44","author":"Dadds","year":"2014","journal-title":"J Autism Dev Disord"},{"key":"B52","doi-asserted-by":"publisher","first-page":"20953","DOI":"10.1073\/pnas.1312857110","article-title":"Oxytocin enhances brain function in children with autism","volume":"110","author":"Gordon","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1469-7610.00715","article-title":"The \u00e2\u20ac\u0153reading the mind in the eyes\u00e2\u20ac\u009d test, revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism","volume":"42","author":"Baron-Cohen","year":"2001","journal-title":"J Child Psychol Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/B978-0-444-63327-9.00007-2","article-title":"Brain mechanisms of plasticity in response to treatment for core deficits in autism","volume":"207","author":"Ventola","year":"2013","journal-title":"Prog Brain Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10803-012-1683-9","article-title":"Neural mechanisms of improvements in social motivation after pivotal response treatment: two case studies","volume":"43","author":"Voos","year":"2013","journal-title":"J Autism Dev Disord"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jaac.2012.08.018","article-title":"Early behavioral intervention is associated with normalized brain activity in young children with autism","volume":"51","author":"Dawson","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T15:16:15Z","timestamp":1498144575000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2014.00061\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,20]]},"references-count":56,"URL":"https:\/\/doi.org\/10.3389\/fped.2014.00061","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,20]]}}}